Sep 22, 2017 - Bernstein sees opportunity in a buyout target.
Sep 12, 2017 - Berkshire Hathaway sold GE, but there's an even better stock for those who want to get in on the ground floor of 21st-century manufacturing.
Sep 06, 2017 - Last summer, the diabetes-focused pharmaceutical issued distressing guidance due to pricing pressure worries, but the forecast troubles failed to arrive.
Sep 06, 2017 - Merck's (MRK) Keytruda received approval in the EU for the first and second line treatment of certain patients with advanced bladder cancer.
Sep 05, 2017 - An update on bariticinib's review timeline has Wall Street rightly excited.
Sep 01, 2017 - How do Eli Lilly and Pfizer fare in a head-to-head matchup between the two big pharma stocks?
Aug 31, 2017 - Lilly (LLY) and Incyte announced that they will re-submit the new drug application (NDA) for their rheumatoid arthritis (RA) drug, baricitinib much faster than previously expected.
Aug 22, 2017 - Eli Lilly, Incyte, and Johnson & Johnson could have the most exciting late-stage oncology candidates.
Aug 07, 2017 - Despite sharing upbeat news, shares of the clinical-stage biotech fell by double-digits.
Aug 07, 2017 - The string of earnings beat failed to boost pharma ETFs.